CAMP4 Gross Profit from 2010 to 2024

CAMP Stock

USD 4.69 0.25 5.06%

CAMP4 THERAPEUTICS Gross Profit yearly trend continues to be relatively stable with very little volatility. Gross Profit is likely to grow to about 84.1 M this year. Gross Profit is the profit CAMP4 THERAPEUTICS PORATION makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

67 M

Current Value

84.1 M

Quarterly Volatility

16.8 M

Credit Downgrade

Yuan Drop

Covid

Check CAMP4 THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CAMP4 THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17.8 M, Interest Expense of 8.3 M or Selling General Administrative of 36.9 M, as well as many indicators such as Price To Sales Ratio of 1.4, Ptb Ratio of 70.11 or Capex To Depreciation of 0.84. CAMP4 financial statements analysis is a perfect complement when working with CAMP4 THERAPEUTICS Valuation or Volatility modules.

Check out the analysis of CAMP4 THERAPEUTICS Correlation against competitors.

Latest CAMP4 THERAPEUTICS's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of CAMP4 THERAPEUTICS PORATION over the last few years. Gross profit is a required income statement account that reflects total revenue of CAMP4 THERAPEUTICS PORATION minus its cost of goods sold. It is profit before CAMP4 THERAPEUTICS operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. CAMP4 THERAPEUTICS's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CAMP4 THERAPEUTICS's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

CAMP4 Gross Profit Regression Statistics

	Arithmetic Mean	115,225,813
	Geometric Mean	113,757,897
	Coefficient Of Variation	14.58
	Mean Deviation	11,417,499
	Median	122,405,000
	Standard Deviation	16,795,471
	Sample Variance	282.1T
	Range	55.4M
	R-Value	(0.64)
	Mean Square Error	180.4T
	R-Squared	0.41
	Significance	0.01
	Slope	(2,393,013)
	Total Sum of Squares	3949.2T

CAMP4 Gross Profit History

	2024	84.1 M
	2023	67 M
	2022	109 M
	2021	121.9 M

Other Fundumenentals of CAMP4 THERAPEUTICS

Gross Profit Margin

CAMP4 THERAPEUTICS Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Invested Capital	Capital Stock	Net Working Capital
Total Assets		0.99	0.89	-0.73	0.77	0.72	-0.62	0.94	0.94	1.0	0.77	0.85	-0.95	0.96	0.91	0.95
Total Stockholder Equity	0.99		0.93	-0.79	0.83	0.61	-0.66	0.95	0.9	0.99	0.82	0.91	-0.96	0.92	0.87	0.92
Current Deferred Revenue	0.89	0.93		-0.78	0.95	0.37	-0.52	0.92	0.78	0.91	0.91	0.98	-0.9	0.74	0.69	0.74
Net Debt	-0.73	-0.79	-0.78		-0.62	-0.31	0.92	-0.62	-0.69	-0.74	-0.59	-0.78	0.87	-0.63	-0.48	-0.72
Retained Earnings	0.77	0.83	0.95	-0.62		0.18	-0.3	0.91	0.65	0.8	0.99	0.97	-0.78	0.59	0.56	0.57
Accounts Payable	0.72	0.61	0.37	-0.31	0.18		-0.43	0.52	0.81	0.69	0.18	0.27	-0.6	0.86	0.81	0.85
Net Receivables	-0.62	-0.66	-0.52	0.92	-0.3	-0.43		-0.42	-0.62	-0.62	-0.28	-0.51	0.75	-0.63	-0.47	-0.72
Good Will	0.94	0.95	0.92	-0.62	0.91	0.52	-0.42		0.83	0.95	0.91	0.92	-0.88	0.85	0.84	0.81
Total Liab	0.94	0.9	0.78	-0.69	0.65	0.81	-0.62	0.83		0.93	0.66	0.75	-0.94	0.92	0.8	0.97
Total Current Assets	1.0	0.99	0.91	-0.74	0.8	0.69	-0.62	0.95	0.93		0.79	0.87	-0.95	0.95	0.9	0.94
Short Term Debt	0.77	0.82	0.91	-0.59	0.99	0.18	-0.28	0.91	0.66	0.79		0.96	-0.78	0.58	0.55	0.58
Intangible Assets	0.85	0.91	0.98	-0.78	0.97	0.27	-0.51	0.92	0.75	0.87	0.96		-0.9	0.68	0.62	0.7
Common Stock	-0.95	-0.96	-0.9	0.87	-0.78	-0.6	0.75	-0.88	-0.94	-0.95	-0.78	-0.9		-0.87	-0.75	-0.93
Net Invested Capital	0.96	0.92	0.74	-0.63	0.59	0.86	-0.63	0.85	0.92	0.95	0.58	0.68	-0.87		0.96	0.98
Capital Stock	0.91	0.87	0.69	-0.48	0.56	0.81	-0.47	0.84	0.8	0.9	0.55	0.62	-0.75	0.96		0.88
Net Working Capital	0.95	0.92	0.74	-0.72	0.57	0.85	-0.72	0.81	0.97	0.94	0.58	0.7	-0.93	0.98	0.88

Click cells to compare fundamentals

About CAMP4 THERAPEUTICS Financial Statements

CAMP4 THERAPEUTICS shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although CAMP4 THERAPEUTICS investors may analyze each financial statement separately, they are all interrelated. The changes in CAMP4 THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses on on CAMP4 THERAPEUTICS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	67 M	84.1 M
Gross Profit Margin	0.36	0.25

Pair Trading with CAMP4 THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.

Moving against CAMP4 Stock

0.67	VINC	Vincerx Pharma	Pair Corr
0.42	DTIL	Precision BioSciences	Pair Corr
0.32	DRMA	Dermata Therapeutics	Pair Corr
0.31	VCNX	Vaccinex	Pair Corr
0.31	DRTS	Alpha Tau Medical	Pair Corr

The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.

The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC